Home › NDC Lookup › RxCUI directory › RxCUI 308805

Brinzolamide 10 MG/ML Ophthalmic Suspension — RxCUI 308805

RxNorm drug concept · Semantic clinical drug
RxCUI 308805 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI308805
Official nameBrinzolamide 10 MG/ML Ophthalmic Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbrinzolamide 1 % Ophthalmic Suspension
FDA products mapped6
Package NDCs mapped12
Reported Medicaid activity (SDUD)7,791 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Brinzolamide Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's lowering the pressure inside your eye. Your eye constantly makes a fluid called aqueous humor, and if it builds up too much, pressure rises. High eye pressure can slowly damag...
  • What exactly is brinzolamide treating in my eye?
  • Yes, completely normal. A bitter, sour, or unusual taste is one of the most commonly reported side effects, affecting up to about 1 in 10 people. It happens because some of the dro...
  • I noticed a weird bitter taste after putting in the drops — is that normal?
📖 Read our full Brinzolamide Ophthalmic guide →

🕸️ Concept Web — How Brinzolamide 10 MG/ML Ophthalmic Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Brinzolamide 10 MG/ML Ophthalmic Suspension RxCUI 308805

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Brinzolamide 194881
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Azopt 194882
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Brinzolamide Ophthalmic Suspension 371112
    • Brinzolamide Ophthalmic Product 1163095
    • Brinzolamide Ophthalmic Suspension [Azopt] 365814
    • Azopt Ophthalmic Product 1166086
    • Ophthalmic Suspension 316964
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Brinzolamide 10 MG/ML SCDC · 329604
  • Brinzolamide Ophthalmic Suspension SCDF · 371112
  • Brinzolamide Ophthalmic Product SCDG · 1163095

Brand-Name Concepts

📦 FDA Products & Package NDCs

6 products · 12 package NDCs
12 package NDCs map to RxCUI 308805 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00574-4012-10 1 BOTTLE in 1 CARTON (0574-4012-10) / 10 mL in 1 BOTTLE BRINZOLAMIDE Padagis US LLC 2023-10-10
00574-4012-15 1 BOTTLE in 1 CARTON (0574-4012-15) / 15 mL in 1 BOTTLE BRINZOLAMIDE Padagis US LLC 2023-10-10
00781-6014-70 1 BOTTLE, PLASTIC in 1 CARTON (0781-6014-70) / 10 mL in 1 B... Brinzolamide Sandoz Inc 2021-03-08
00781-6014-85 1 BOTTLE, PLASTIC in 1 CARTON (0781-6014-85) / 15 mL in 1 B... Brinzolamide Sandoz Inc 2021-03-08
24208-0464-10 1 BOTTLE, PLASTIC in 1 CARTON (24208-464-10) / 10 mL in 1 B... BRINZOLAMIDE Bausch & Lomb Incorporated 2022-03-31
24208-0464-15 1 BOTTLE, PLASTIC in 1 CARTON (24208-464-15) / 15 mL in 1 B... BRINZOLAMIDE Bausch & Lomb Incorporated 2022-03-31
66758-0085-70 1 BOTTLE in 1 CARTON (66758-085-70) / 10 mL in 1 BOTTLE Azopt Sandoz Inc 2024-10-25
66758-0085-85 1 BOTTLE in 1 CARTON (66758-085-85) / 15 mL in 1 BOTTLE Azopt Sandoz Inc 2024-11-15
68682-0464-10 1 BOTTLE, PLASTIC in 1 CARTON (68682-464-10) / 10 mL in 1 B... BRINZOLAMIDE Oceanside Pharmaceuticals. 2021-08-25
68682-0464-15 1 BOTTLE, PLASTIC in 1 CARTON (68682-464-15) / 15 mL in 1 B... BRINZOLAMIDE Oceanside Pharmaceuticals. 2021-08-25
72162-2201-02 1 BOTTLE in 1 CARTON (72162-2201-2) / 10 mL in 1 BOTTLE BRINZOLAMIDE Bryant Ranch Prepack 2023-12-19
72162-2201-04 1 BOTTLE in 1 CARTON (72162-2201-4) / 15 mL in 1 BOTTLE BRINZOLAMIDE Bryant Ranch Prepack 2023-12-19
Observed labelers: Sandoz Inc (4) · Bausch & Lomb Incorporated (2) · Bryant Ranch Prepack (2) · Oceanside Pharmaceuticals. (2) · Padagis US LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$10.3303
Range $10.0197–$35.2328 · middle 50% $10.0197–$16.5348 · 8 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.